Mehdi Abbasnejad

Mehdi Abbasnejad

Auto-generated profile, based on publicly available information

Mehdi Abbasnejad

Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Rejuvenation Research
Verified
Journal Article
Closed access
HPHamzeh Pasban-Aliabadi
Hamzeh Pasban-Aliabadi
SESaeed Esmaeili-Mahani
Saeed Esmaeili-Mahani
MAMehdi Abbasnejad
Mehdi Abbasnejad
Parkinson's disease (PD) is a common neurodegenerative disorder that is characterized by progressive and selective death of dopaminergic neurons. Multifunctional neuropeptide orexin-A is involved in many biological events of the body. It has been shown that orexin-A has protective effects in neurodegenerative disease such as PD. However, its cellular mechanisms have not yet been fully clarified. Here, we investigated the intracellular signaling pathway of orexin-A neuroprotection in 6-hydroxydopamine (6-OHDA)-induced SH-SY5H cells damage as an in vitro model of PD. The cells were incubated with 150 μM 6-OHDA, and the viability was examined by 3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2-tetrazolium bromide (MTT) assay. Mitochondrial membrane potential and intracellular calcium were measured by fluorescent probes. Western blotting was also used to determine cyclooxygenase type 2 (COX-2), nuclear factor erythroid 2 related factor 2 (Nrf2), and HSP70 protein levels. The data showed that 6-OHDA has decreasing effects on cell viability, Nrf2, and HSP70 protein expression and increases the level of mitochondrial membrane potential, intracellular calcium, and COX-2 protein. Orexin-A (500 pM) significantly attenuated the 6-OHDA-induced cell damage. Furthermore, Orexin-A significantly prevented the mentioned effects of 6-OHDA on SH-SY5Y cells. Orexin 1 receptor antagonist (SB3344867), PKC, and PI3-kinase (PI3K) inhibitors (chelerythrin and LY294002, respectively) could suppress the orexin-A neuroprotective effect. In contrast, blockage of PKA by a selective inhibitor (KT5720) had no effects on the orexin protection. The results suggest that orexin-A protective effects against 6-OHDA-induced neurotoxicity are performed via its receptors, PKC and PI3K signaling pathways.


1 November 2020 in Neuropharmacology
Verified
Journal Article
Closed access
RKRazieh Kooshki
Razieh Kooshki
MAMehdi Abbasnejad
Mehdi Abbasnejad
SESaeed Esmaeili-Mahani
Saeed Esmaeili-Mahani
MRMaryam Raoof
Maryam Raoof
VSVahid Sheibani
Vahid Sheibani

1 July 2019 in International Journal of Neuroscience
Verified
Journal Article
Closed access
AKAli Khorasani
Ali Khorasani
MAMehdi Abbasnejad
Mehdi Abbasnejad
SESaeed Esmaeili-Mahani
Saeed Esmaeili-Mahani
Alzheimer's disease (AD) is characterized by oxidative stress, neuroinflammation and progressive cognitive decline. Abscisic acid (ABA) is produced in a variety of mammalian tissues, including brain. It has anti-inflammatory and antioxidant effects and elicits a positive effect on spatial learning and memory performance. Here, the possible protective effect of ABA was evaluated in streptozotocin (STZ)-induced AD rat model which were injected intracerebroventriculary (i.c.v.) with STZ (3 mg/kg). The STZ-treated animals received ABA (10 μg/rat, i.c.v.), ABA plus PPARβ/δ receptor antagonist (GSK0660, 80 nM/rat) or ABA plus selective inhibitor of PKA (KT5720, 0.5 μg/rat) for 14 days. Learning and memory were determined using Morris water maze (MWM) and passive avoidance (PA) tests. The results showed that STZ produced a significant learning and memory deficit in both MWM and PA tests. ABA significantly prevented the learning and memory impairment in STZ-treated rats. However, ABA effects were blocked by GSK0660 and KT5720. The data indicated that ABA attenuates STZ-induced learning and memory impairment and PPAR-β/δ receptors and PKA signaling are involved, at least in part, in the ABA mechanism.

1 December 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RNReyhaneh Naderi
Reyhaneh Naderi
SESaeed Esmaeili-Mahani
Saeed Esmaeili-Mahani
MAMehdi Abbasnejad
Mehdi Abbasnejad

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RNReyhaneh Naderi
Reyhaneh Naderi
SESaeed Esmaeili-Mahani
Saeed Esmaeili-Mahani
MAMehdi Abbasnejad
Mehdi Abbasnejad
Abscisic acid (ABA), a critical phytohormone, is also produced in animal tissues. It has been reported that ABA has pro-cognitive and anti-anxiety effects in rats. However, its detailed mechanism has not yet been clarified. Here, the possible roles of extracellular and intracellular calcium store and ERK signaling were evaluated in pro-cognitive and anti-anxiety effects of ABA. Morris water maze (MWM) and plus maze tests were used to evaluate the learning and memory and anxiety-like behavior, respectively, in rats. The inhibitors of L- (nifedipine) and T-type (amiloride) calcium channels and endoplasmic reticulum Ca2+-ATPase (thapsigargin) were centrally (i.c.v.) injected 15 min before ABA. Hippocampal and prefrontal lobe levels of phosphorylated extracellular signal-regulated Kinase (p-ERK) were assessed by immunoblotting. The data showed that ABA has promoting effect on rat's performance in MWM task and induced anti-anxiety effect. In addition, nifedipine and thapsigargin significantly prevented while, amiloride had no effect on the mentioned effects of ABA. Furthermore, p-ERK levels were significantly increased in ABA-treated rats which were inhibited by nifedipine and thapsigargin pretreatment. It seems that the extracellular calcium influx through L-type calcium channels, intracellular calcium storage and ERK signaling are involved, at least in part, in the pro-cognitive and anti-anxiety effects of ABA.